Ceredex Value Advisors’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,081,600
Closed -$78.7M 172
2022
Q4
$78.7M Sell
4,081,600
-427,300
-9% -$8.39M 1.21% 24
2022
Q3
$94M Buy
4,508,900
+1,987,700
+79% +$50.5M 1.53% 15
2022
Q2
$70.4M Buy
+2,521,200
New +$74.9M 1.05% 31
2021
Q3
Sell
-576,225
Closed -$15.6M 135
2021
Q2
$15.6M Sell
576,225
-1,346,700
-70% -$38.1M 0.17% 112
2021
Q1
$53.6M Sell
1,922,925
-109,000
-5% -$3.05M 0.62% 63
2020
Q4
$56M Buy
2,031,925
+13,525
+0.7% +$357K 0.71% 54
2020
Q3
$52.5M Buy
2,018,400
+62,500
+3% +$1.64M 0.77% 51
2020
Q2
$51.9M Hold
1,955,900
0.77% 60
2020
Q1
$47.5M Buy
+1,955,900
New +$59.1M 0.81% 50

Other funds holding HR

Ceredex Value Advisors's HR Position: Q1 2023 in Review

Ceredex Value Advisors sold out of Healthcare Realty (HR) in Q1 2023, closing a stake of 4,081,600 shares — an estimated $78.7M sold.

Ceredex Value Advisors first reported a position in HR in Q1 2020 and held it in 9 quarters. The position peaked at $94M in Q3 2022. 419 funds tracked by Wall St. Rank hold HR as of Q1 2023.

  • Ceredex Value Advisors reported no remaining Healthcare Realty position as of Q1 2023 after selling out during the quarter.
  • Ceredex Value Advisors sold 4,081,600 Healthcare Realty shares in Q1 2023, an estimated $78.7M.
  • Ceredex Value Advisors first reported a position in Healthcare Realty in Q1 2020 and held it in 9 quarters.
  • Ceredex Value Advisors's Healthcare Realty position peaked at $94M in Q3 2022.
  • 419 funds tracked by Wall St. Rank held Healthcare Realty as of Q1 2023.

Based on Ceredex Value Advisors's 13F filing for Q1 2023, filed 26 Apr 2023.